These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3475207)

  • 21. Effect of norfloxacin on theophylline metabolism.
    Davis RL; Kelly HW; Quenzer RW; Standefer J; Steinberg B; Gallegos J
    Antimicrob Agents Chemother; 1989 Feb; 33(2):212-4. PubMed ID: 2719466
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of norfloxacin on theophylline disposition: a comparison with other fluoroquinolones.
    Davis JD; Aarons L; Houston JB
    Pharm Res; 1995 Feb; 12(2):257-62. PubMed ID: 7784342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibitory effect of enoxacin, ofloxacin and norfloxacin on renal excretion of theophylline in humans.
    Sano M; Kawakatsu K; Yamamoto I; Takeyama M; Yamashina H; Goto M
    Eur J Clin Pharmacol; 1989; 36(3):323-4. PubMed ID: 2744074
    [No Abstract]   [Full Text] [Related]  

  • 24. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Comparative activities in vitro of 4 quinolones (nalidixic acid, pefloxacin, norfloxacin, ofloxacin) on 13 bacterial species].
    Rahal K
    Arch Inst Pasteur Alger; 1992; 58():41-84. PubMed ID: 1309146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man.
    Wijnands GJ; Cornel JH; Martea M; Vree TB
    Chest; 1990 Dec; 98(6):1440-4. PubMed ID: 2245687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interactions of fluoroquinolones with other drugs: mechanisms, variability, clinical significance, and management.
    Radandt JM; Marchbanks CR; Dudley MN
    Clin Infect Dis; 1992 Jan; 14(1):272-84. PubMed ID: 1571442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction between the fluoroquinolones and the bronchodilator theophylline.
    Wijnands WJ; Vree TB
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():109-14. PubMed ID: 3053575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of quinolone derivatives on theophylline clearance.
    Wijnands WJ; Vree TB; van Herwaarden CL
    Br J Clin Pharmacol; 1986 Dec; 22(6):677-83. PubMed ID: 3567014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative bacteriologic activity of norfloxacin, ofloxacin and pefloxacin against 320 Gram-negative bacilli resistant and non-resistant to nalidixic acid and cephalosporins].
    Croize J; Le Noc P; Bryskier A; Robert J
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):564-8. PubMed ID: 3937128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of oral ofloxacin on fecal bacteria in human volunteers.
    Pecquet S; Andremont A; Tancrède C
    Antimicrob Agents Chemother; 1987 Jan; 31(1):124-5. PubMed ID: 3471178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [In vitro comparative activity of norfloxacin in the comparison of pathogenic bacteria of the urinary tract].
    Carlone NA; Cuffini AM; Tullio V; Savoia D; Cavallo GP
    G Batteriol Virol Immunol; 1986; 79(1-6):85-97. PubMed ID: 3479370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the effect of norfloxacin on the pharmacokinetics of theophylline.
    Ho G; Tierney MG; Dales RE
    Clin Pharmacol Ther; 1988 Jul; 44(1):35-8. PubMed ID: 3391003
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of effect of gemifloxacin on the steady-state pharmacokinetics of theophylline in healthy volunteers.
    Davy M; Allen A; Bird N; Rost KL; Fuder H
    Chemotherapy; 1999; 45(6):478-84. PubMed ID: 10567778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug-drug interactions affecting fluoroquinolones.
    Wijnands GJ; Vree TB; Janssen TJ; Guelen PJ
    Am J Med; 1989 Dec; 87(6C):47S-51S. PubMed ID: 2603893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. b. Synthetic antibacterial agents].
    Ohno I; Ida S
    Nihon Rinsho; 1987 Mar; 45(3):577-82. PubMed ID: 3298736
    [No Abstract]   [Full Text] [Related]  

  • 39. Effect of quinolones on caffeine disposition.
    Carbó M; Segura J; De la Torre R; Badenas JM; Camí J
    Clin Pharmacol Ther; 1989 Mar; 45(3):234-40. PubMed ID: 2920498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.